Further articles

ICB news, BioInterfaces

Welcome to Nada Ghabach

Nada joined the ICB on September 1st. Find out about her research activities and interests here.

ICB news, BioInterfaces

Welcome to Marta Maria Alves Pereira

Marta Maria Alves Pereira PhD candidate Ms Marta Maria Alves Pereira has been awarded a scholarship from the CAPES Foundation, an agency under the Ministry of Education of Brazil, to spend one month at the Group of Biointerfaces led by Prof. Dr. Oya Tagit. Marta will develop and characterize…

Projects, BioInterfaces

Novel biocompatible and biodegradable polymers for biomedical applications

We design novel bio-based polymers to develop biocompatible and biodegradable nanocarriers as alternatives to e.g. PEG.

Projects, BioInterfaces

Multi-compartment nanofactories for on-site and on demand drug synthesis and delivery

We develop compartmentalized vesicles with internal compartments that can be triggered independently and selectively to release their cargo. Libraries of novel stimuli-responsive block co-polymers are prepared for vesicle formation, and release is actuated by external stimulus such as light, magnetic field, etc.

Projects, BioInterfaces

Nanocarriers for mRNA therapeutics

Combining the stability of polymers with transfection efficiency of lipids, we developed polymer-lipid hybrid nanoparticles, which can be stored as lyophilized powder and display long-term storage stability also in suspension. Lyophilization does not impair transfection efficiency.

Projects, BioInterfaces

Nanomedicine and theranostics

Diverse nanoparticle formulations based on polymers, lipids, and combinations thereof, loaded with (bio)therapeutics such as antimicrobial peptides, small molecule drugs, and nucleic acids are developed to combat infectious diseases and cancer. We further develop inorganic nanoparticles (metal and semiconductor) and drug-conjugated luminescent probes with cleavable linkers for simultaneous therapy and…

Projects, BioInterfaces

Tailor-made nanoparticles

Using top-down and bottom-up synthesis, encapsulation, surface engineering, and bioconjugation approaches, we develop nanoparticles with precisely defined and controlled size, morphology, composition, and surface functionality, and tailor them for the desired biological targets and functions.

×